BP-003

BP-003 is a pediatric antibiotic formulation developed by Brillian Pharma. It is a reformulation of an existing antibiotic agent into the company's proprietary "Unidose" format, which is designed to improve dosing accuracy and patient compliance in children. The product is presented as an oral solution or a lyophilized powder for reconstitution. As a reformulation, BP-003 utilizes the established mechanism of action of its underlying antibiotic active pharmaceutical ingredient (API) to treat bacterial infections, although the specific API has not been publicly disclosed in the company's pipeline. The development focuses on optimizing drug delivery for the pediatric population rather than the discovery of a novel molecular entity.